Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
As of close of business last night, Cg Oncology Inc’s stock clocked out at $33.56, down -6.54% from its previous closing price of $35.91. In other words, the price has decreased by -$6.54 from its previous closing price. On the day, 1.9 million shares were traded. CGON stock price reached its highest trading level at $36.08 during the session, while it also had its lowest trading level at $31.5527.
Ratios:
To gain a deeper understanding of CGON’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 35.32 and its Current Ratio is at 35.32. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, UBS on October 24, 2024, initiated with a Buy rating and assigned the stock a target price of $60.
On September 23, 2024, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $66.
On August 28, 2024, ROTH MKM started tracking the stock assigning a Buy rating and target price of $65.ROTH MKM initiated its Buy rating on August 28, 2024, with a $65 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 29 ’24 when Song Hong Fang sold 650,455 shares for $35.36 per share. The transaction valued at 23,000,089 led to the insider holds 586,982 shares of the business.
Unique Diamond Investments Ltd bought 424,210 shares of CGON for $15,000,000 on Aug 29 ’24. On Aug 29 ’24, another insider, Charming Jade Ltd, who serves as the Director of the company, bought 226,245 shares for $35.36 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CGON now has a Market Capitalization of 2428582912 and an Enterprise Value of 1729237888. For the stock, the TTM Price-to-Sale (P/S) ratio is 3337.72 while its Price-to-Book (P/B) ratio in mrq is 4.22. Its current Enterprise Value per Revenue stands at 2528.126 whereas that against EBITDA is -18.025.
Stock Price History:
Over the past 52 weeks, CGON has reached a high of $50.23, while it has fallen to a 52-week low of $25.77. The 50-Day Moving Average of the stock is -6.50%, while the 200-Day Moving Average is calculated to be -6.50%.
Shares Statistics:
It appears that CGON traded 652.97K shares on average per day over the past three months and 504520 shares per day over the past ten days. A total of 67.54M shares are outstanding, with a floating share count of 41.19M. Insiders hold about 39.10% of the company’s shares, while institutions hold 61.80% stake in the company. Shares short for CGON as of 1731628800 were 5396401 with a Short Ratio of 8.26, compared to 1728950400 on 5957280. Therefore, it implies a Short% of Shares Outstanding of 5396401 and a Short% of Float of 8.06.
